Announcements Trials
Browse Landscape

Status

Active not recruiting 4Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 230Observational 5

Sponsor

Cancer Type

Gastrointestinal 4Breast 1

Conditions

Colorectal Neoplasms 2Unresectable Hepatocellular Carcinoma 1Hemorrhage 1Elderly Metastatic Colorectal Cancer Patients 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 53Blood Specimen Collection 53Specimen Handling 28Radiotherapy 18Observation 18Interviews as Topic 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 10Drug Therapy 10Data Collection 10Biopsy 10Tomography, X-Ray Computed 9darolutamide 8Watchful Waiting 7Standard of Care 7ribociclib 6palbociclib 6Restraint, Physical 6Patient Reported Outcome Measures 6Magnetic Resonance Imaging 6Immune Checkpoint Inhibitors 6trastuzumab deruxtecan 5Positron-Emission Tomography 5Mass Screening 5Genetic Testing 5Esophagectomy 5Breath Tests 5Bevacizumab 5enzalutamide 4apalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Bevacizumab × 90 days × Clear all
NCT07527832 2026-05-22

An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

Pfizer

Recruiting
1,000 enrolled
Gastrointestinal

Hemorrhage, Colorectal Neoplasms

NCT06117891 2026-05-12

REFINE-IO

Bayer

Active not recruiting
300 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Hoffmann-La Roche

Active not recruiting
2,907 enrolled
Breast

Breast Neoplasms

NCT03451370 2026-04-15

COBRA

Istituto Oncologico Veneto IRCCS

Active not recruiting
121 enrolled
Gastrointestinal

Elderly Metastatic Colorectal Cancer Patients

NCT02394834 2026-04-13

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Takeda

Active not recruiting
757 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡